Virgin Atlantic Cargo granted WDA for global headquarters operations and Pharma Zone
Virgin Atlantic Cargo has been granted a Wholesale Distribution Authorisation for its global headquarters operations and Pharma Zone at Heathrow Airport.
May 9, 2018
By Ang Yi An
Virgin Atlantic Cargo has been granted a Wholesale Distribution Authorisation (WDA) for its global headquarters operations and its new Pharma Zone at Heathrow Airport, confirming the airline’s compliance with Good Distribution Practice (GDP) and its ability to maintain the quality and integrity of medicinal products for human use.
WDA was established by the UK Government’s Medicines and Healthcare Products Regulatory Agency (MHRA), which is recognised as a trusted and independent source of expertise throughout Europe, working closely with the European regulator, the European Medicines Agency (EMEA). The MHRA also collaborates with other international regulators, including the US Food and Drug Administration (FDA).
Virgin Atlantic Cargo’s WDA accreditation for its VHQ global headquarters follows its handling partner dnata also gaining WDA for its Cargo Point operation at Heathrow, which incorporates the Pharma Zone, shared by Virgin Atlantic and its joint venture partner, Delta Cargo.
This latest enhancement of Virgin Atlantic’s products and services for pharmaceuticals and life science shipments is expected to lead to further growth in volumes, which rose by over 20% in 2017. In January, the airline also increased the range of active containers it offers for temperature-controlled cargoes by becoming the first UK airline to approve the use of CSafe’s new RAP unit.